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Like vitamin D deficit, magnesium deficit is considered to be a risk factor for cardiovascular disease. Several steps in
the vitamin D metabolism, such as vitamin D binding to its transport protein and the conversion of vitamin D into
the hormonal form 1,25-dihydroxyvitamin D by hepatic and renal hydroxylation, depend on magnesium as a
cofactor. A new analysis of two National Health and Nutrition Examination Surveys data sets, published in BMC
Medicine, investigated potential interactions between magnesium intake, circulating 25-hydroxyvitamin D, which is
the generally accepted indicator of vitamin D status, and mortality. Data indicate a reduced risk of insufficient/deficient
vitamin D status at high magnesium intake and an inverse association between circulating 25-hydroxyvitamin D and
mortality, particularly cardiovascular mortality, among those with magnesium intake above the median. The study
provides important findings concerning potential metabolic interactions between magnesium and vitamin D and
its clinical relevance. However, results should be considered preliminary since biochemical data on individual
magnesium status were lacking, confounding cannot be excluded and questions on the dose–response
relationship still remain to be answered.
Please see related research article: http://www.biomedcentral.com/1741-7015/11/187.
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Life depends on an energy-consuming complex interplay
of organic and inorganic substances to maintain bio-
logical structures. Adequate energy and nutrient supply
is a prerequisite to guarantee normal functioning of
metabolic pathways and thus a healthy life. To become
metabolically active, several nutrients require other es-
sential nutrients as cofactors. For example, copper is re-
quired for the oxidation of absorbed Fe2+ to Fe3+, which
is then bound to transferrin, and riboflavin (vitamin B2)
and pyridoxine (vitamin B6) are required to produce nia-
cin (vitamin B3) from dietary tryptophan. Therefore,
some nutrition-related illnesses, such as anemia and pel-
lagra, can be caused by multiple nutrient deficits [1,2].
Magnesium (Mg) is a cofactor that is required for the
binding of vitamin D to its transport protein. Moreover,
conversion of vitamin D by hepatic 25-hydroxlation and
renal 1α-hydroxylation into the active, hormonal formCorrespondence: azittermann@hdz-nrw.de
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20131,25-dihydroxyvitamin D (1,25(OH)2D) is Mg-dependent
[3,4]. A study by Deng et al. [5], published in BMC
Medicine, investigated potential interactions between
Mg intake, vitamin D status and mortality. Still, some
questions remain open.Study results
Deng et al. [5] used two large National Health and Nutri-
tion Examination Surveys data sets to assess interactions
between Mg intake, vitamin D status and outcome.
According to the Institute of Medicine (IOM) classifica-
tion, circulating 25-hydroxyvitamin D (25OHD), the gen-
erally accepted indicator of vitamin D status, was within
the deficit range (<12 ng/ml) in 12% of participants and
the insufficiency range (12 to 20 ng/ml) [6] in 30%. Mean
energy-adjusted total Mg intake (dietary and supplemen-
tal) was clearly below the recommended daily allowance,
which is between 310 and 420 mg depending on age and
gender [7]. High Mg intake was associated with reduced
risk of vitamin D deficit or insufficiency. Data also indicate
an inverse association between circulating 25OHD andtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Zittermann BMC Medicine Page 2 of 32013, 11:229
http://www.biomedcentral.com/1741-7015/11/229mortality, particularly cardiovascular mortality, among
those with Mg intake above the median.
Vitamin D status and its predictors
The present data are consistent with the assumption that
deficient vitamin D levels are an important health issue
that may affect not only musculoskeletal health but also
a wide range of acute and chronic diseases [8]. The high
prevalence of deficient 25OHD blood levels in the popu-
lation is believed to be primarily due to inadequate vita-
min D synthesis in the skin, together with inadequate
dietary intake [9]. However, circulating 25OHD levels
also depend on body weight and genetic factors, and a
significant portion of the variance in circulating 25OHD
remains unexplained at present. Therefore, Deng et al.
are to be commended for investigating potential interac-
tions between Mg and vitamin D status. Especially with
regard to vitamin D, there is still ongoing debate regard-
ing the optimal oral intake and the adequate circulating
25OHD level. The IOM recommends a daily vitamin D
intake of 600 international units and considers circulat-
ing 25OHD levels of 20 to 50 ng/ml as adequate, and
25OHD levels above 50 ng/ml as potentially harmful [6].
However, according to the Endocrine Society [10], the
circulating 25OHD level should be within the range of
30 to 100 ng/ml. To raise the 25OHD level consistently
above 30 ng/ml, they recommend a daily vitamin D in-
take of 1,500 to 2,000 international units.
Open questions
Like vitamin D deficit [11], Mg deficit is considered to
be a risk factor for cardiovascular disease [12]. Thus,
the presented interactions between Mg, vitamin D and
cardiovascular mortality fit well together. Nevertheless,
for several reasons, data should be considered prelimin-
ary. First, associations are based on oral Mg intake. The
assessment of oral Mg intake does not take into account
inter-individual differences in intestinal Mg absorption
and renal and cutaneous Mg loss. It would have been
more appropriate to use biochemical data, such as
plasma Mg levels (levels of 0.79 to 0.76 mmol/l have
been classified as inadequate and levels <0.76 mmol/l as
deficient), to assess individual Mg status. Unfortunately,
plasma levels of Mg are still rarely assessed, whereas
measurement of circulating 25OHD levels has exploded
in the clinical setting in recent years [13]. Second, total
Mg intake, 25OHD status and physical activity level
were clearly interrelated [5]. High Mg intake may thus
only be an indicator for high physical activity, which is
known to influence 25OHD status (and cardiovascular
mortality). Even adjustment for physical activity may not
completely solve the problem of potential bias. Third, no
data on circulating levels of the biologically active form
of vitamin D, 1,25(OH)2D, were presented. Circulating1,25(OH)2D is probably a better predictor of total mor-
tality compared with circulating 25OHD, at least if mid-
term mortality is assessed [14]. Circulating 1,25(OH)2D
declines significantly (and parathyroid hormone levels
increase substantially) at 25OHD levels below 10 ng/ml,
whereas levels of both hormones seem to plateau at
25OHD levels of 20 ng/ml [15]. Notably, three out of
the four 25OHD categories in the mortality analysis of
the present investigation were above 20 ng/ml, and none
covered the range that the IOM has classified as defi-
cient. It would have been interesting to see whether the
combination of inadequate Mg intake with 25OHD
levels below 12 ng/ml is associated with a further mor-
tality increase.
Conclusion
The present study must be praised for bringing potential
interactions between individual nutrients into the focus of
interest. Because the intake of Mg is often inadequate and
several other factors are also known to impair Mg supply
(for example, diuretics use, diabetes mellitus, chronic alco-
hol consumption, stress factors) [16-18], more attention
should in future be paid to possible consequences of insuf-
ficient or deficient Mg supply in the general population.
Further studies on the interactions between Mg supply
and vitamin D status should include a more detailed
assessment of individual Mg status (for example, by meas-
uring biochemical parameters of Mg status or by adjusting
statistical analysis for stress factors, diuretics use, alcohol
consumption and concomitant diagnoses such as dia-
betes); a more detailed investigation of different compo-
nents of the vitamin D-parathyroid hormone axis in
general populations; clarification of the dose–response re-
lationship; and the realization of randomized controlled
trials to verify whether oral Mg is indeed able to improve
vitamin D status and survival.
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